From NICE CG 104, 2010 Table 1 Terms used in this guideline

Slides:



Advertisements
Similar presentations
1 TCR TUMOUR MATCHING ALGORITHM The structure of the algorithm- Heather Bourne Using the algorithm - Jason Hiscox.
Advertisements

Clinical background: Patient RM, YoB 1966 Her family were originally referred because of a history of breast and ovarian cancer. BRCA testing found a missense.
Cancer of Unknown Primary
1 Renal Pelvis, Ureter, Bladder and Other Urinary.
Cancer of Unknown Primary Dr Chris Jones Consultant Medical Oncologist North of England Cancer Network Annual Conference 20 September 2013.
An 80-year-old female presented with an ulcerated nodule on the left cheek. An excision was performed.
AUDIT OF COMPLIANCE WITH NHSCSP GUIDELINES REQUIRING MDT REVIEW OF ALL CERVICAL CANCER PATIENTS Dr. M Bhattacharjee Dr. A Mutton Dr. S Nagarajan.
Tumour Matching N.Ireland Experience Colin Fox (IT Manager) Richard Middleton (Data Manager)
Delving into the Occult. Introduction Occult From the Latin word occultus meaning clandestine, hidden or secret Occult Cancer Carcinoma of unknown primary.
Procedures used by CHTN
1 Colon MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007.
Joint Hospital Surgical Grand Round 21 st July, 2012 RH.
Acute Oncology Service (AOS) Monday – Friday 8am – 4pm Bleep: 946 T: x5726 F: Dr Nicola Beech Dr Jillian Noble Dr Susannah.
1 LUNG. 2 Equivalent Terms, Def, Charts, Tables, Illustrations.
How to manage suspected cancer
1 MP/H Coding Rules General Instructions MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007.
Management of ovarian cysts
Unknown primary tumors : common misdiagnosis Oscar Nappi UOSC di Anatomia patologica AORN A. Cardarelli - Napoli.
The Pathology of Anal Neoplasia Dr Bryan F Warren Consultant Gastrointestinal Pathologist, Honorary Senior Lecturer and Fellow of Linacre College, Oxford.
Statistics about unknown primary tumors Riccardo Capocaccia National Centre for Epidemiology, Surveillance and Health Promotion Istituto Superiore di Sanità,
Notes by Dr Sanjay A Pai. Neoplasm An abnormal proliferation of cells, resulting in a mass called a neoplasm.
Liver Fine needle aspiration using Liquid Based Cytology G Simone, M Asselti, G Caldarola-Gadaleta, T Addati, G Giannone, M Liuzzi, F Palma, V Rubini,
Diagnostic Challenge Pathology for Neurosurgery & Neurology Residents Department of Pathology University of Oklahoma Health Sciences Center, Oklahoma City,
Case 1 Diagnostic possibilities Your diagnoses (%) Small cell carcinoma 4 Adenoid cystic carcinoma 30 Carcinoid49 No answer DIAGNOSTIC CYTOLOGY SEMINAR.
The treatment of metastatic squamous cell carcinoma (SCCA) of the anal canal: A single institution experience P. Pathak, B. King, A. Ohinata, P. Das, C.H.
April 2014 Dr J King Dr K Syred.  90% mesotheliomas are linked to asbestos exposure  May be eligible for compensation  3 yr survival rate 8%  Subtype.
Cancer 101: A Cancer Education and Training Program for American Indians & Alaska Natives Cancer 101: A Cancer Education and Training Program for American.
Cancer Outcomes and Services Dataset Linda Wintersgill Information & Audit Manager, NECN.
New Data Items MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007.
Vulvar Cancer Women’s Hospital,School of Medicine Zhejiang University.
Provisional MUO Audit Tania Tillett Medical Oncologist RUH.
The management of low-risk basal cell carcinomas in the community Implementing NICE guidance in general practice May 2010 NICE guidance on cancer services.
Pathology of lung cancer: Case #1 presentation. 38-year-old man, non smoker, unremarkable family and personal clinical history productive cough since.
The Cancer Registry of Norway Jan F Nygård Head of the IT-department.
1 Virginia Cancer Registrars Association and Virginia Cancer Registry Annual Meeting October 3, 2007.
Annals of Oncology 23: 298–304, 2012 종양혈액내과 R4 김태영 / prof. 김시영.
1. Multiple Primary and Histology Rules 101 Format of MP/H Materials.
R2 김재민 / Prof. 정재헌 Journal conference 1.
Metastases to the breast. 49-year-old woman Palpable lump in the left breast.
Module Leader: Louise Jones
Consultant Medical Oncologist
Large cell undifferentiated carcinoma of lung
Wijendra Senarathne1, Peggy Gates1, Semir Vranic2, Zoran Gatalica1
Table 3. Age Distribution of Solid Malignant Tumours in Children
Principles of Surgical Oncology
NECK MASSES.
TUMORS OF THE KIDNEY AND URINARY BLADDER
Dorset County Hospital Cancer of Unknown Primary (CUP) Service
Pathway for patients with suspected Breast Cancer
Hybrid Model Integrating Immunohistochemistry and Expression Profiling for the Classification of Carcinomas of Unknown Primary Site  Barbara A. Centeno,
What’s New for 8th Edition
Pathway for patients with suspected Skin Cancer
Vulvar Cancer Women’s Hospital,School of Medicine Zhejiang University.
عنوان: بررسي فراواني انواع كانسرهاي تيروئيد از نظر زير گروه هيستوپاتولوژيك، توزيع سني، جنسي و محل آناتوميك آن در انستيتو كانسر و امام در طي سالهاي 1381.
Figure 2 Examples of histopathological validation
Comparison of the nADC value and CNR on T2-weighted images of 26 metastatic brain tumors of different histologic types. Comparison of the nADC value and.
NEOPLASM DIAGNOSIS CODING AND SEQUENCING
Pathway for patients with suspected HPB Cancer Inter Provider Transfer
Skin cancer primary tumour (pT) staging changes from Jan 2018
Radiological imaging in primary parotid malignancy
1st half GP cancer event youtube. com/watch
Pathway for patients with suspected Breast Cancer
Combined data from RISC (n=3,024) and San Raffaele dataset (n=1,067)
Figure 3 Determination of the primary site
CUP is a clinico-pathological syndrome of many specific cancer
ROYAL COLLEGE OF PHYSICIANS,
Comparison of the nADC value and CNR on T2-weighted images of 13 histologically confirmed brain lesions. Comparison of the nADC value and CNR on T2-weighted.
Airedale NHS Foundation Trust
SCC MDT Service Evaluation
Figure 12a Pitfalls in N staging at CT and PET
Presentation transcript:

From NICE CG 104, 2010 Table 1 Terms used in this guideline Malignancy of undefined primary origin (MUO) Metastatic malignancy identified on the basis of a limited number of tests, without an obvious primary site, before comprehensive investigation. Provisional carcinoma of unknown primary origin (provisional CUP) Metastatic epithelial or neuro-endocrine malignancy identified on the basis of histology or cytology, with no primary site detected despite a selected initial screen of investigations, before specialist review and possible further specialised investigations. Confirmed carcinoma of unknown primary origin (confirmed CUP) Metastatic epithelial or neuro-endocrine malignancy identified on the basis of final histology, with no primary site detected despite a selected initial screen of investigations, specialist review, and further specialised investigations as appropriate. From NICE CG 104, 2010

Pathological Approach Confirm malignancy Exclude - Germ cell - Lymphoma - melanoma - sarcoma Subdivide carcinoma – squamous or urothelial - neuroendocrine - solid organ - adenocarcinoma Look for markers of possible/likely primary site

CUP dataset – only complete for confirmed CUP Diagnosis of exclusion requiring consideration of imaging, clinical picture including past history, tumour markers, MDT discussion. Dataset records negative/equivocal/positive immuno findings leading to CUP diagnosis. CUP/MUO worksheet